Business Context and Reporting Period
Company: Baxter International Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 29, 2006
Reporting Period: Single event date (June 29, 2006)
This filing reports the entry into a Material Definitive Agreement by Baxter Healthcare Corporation, a direct wholly-owned subsidiary of Baxter International Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a legal settlement rather than periodic financial performance.
Material Changes
Legal Resolution: On June 29, 2006, Baxter Healthcare Corporation entered into a Consent Decree for Condemnation and Permanent Injunction with the United States.
Subject Matter: The agreement resolves previously reported seizure litigation concerning Baxter's COLLEAGUE and SYNDEO infusion pumps.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the resolution of the specific litigation regarding the seizure of medical devices.
Risks and Contingencies: The primary risk addressed is the legal uncertainty surrounding the COLLEAGUE and SYNDEO pumps, which has been mitigated through the Consent Decree. The filing does not provide forward-looking financial guidance or discuss other operational risks.
Investor Verification Checklist
- Review the full text of the Consent Decree (Exhibit 10.1) to understand the specific terms of the condemnation and permanent injunction.
- Verify the financial impact of the seizure litigation and the settlement terms on future earnings or asset valuation.
- Confirm the operational status of the COLLEAGUE and SYNDEO pump product lines following the injunction.
- Check for any subsequent filings regarding the implementation of the Consent Decree.